Showing results (61-70 of 5,481) with videos related to
Sort By:
Pageof 549
Clinical and Experimental Dermatology|December 2, 2021
Achenbach syndrome in an older manY Mizuno, Y Norimatsu, Y OhnoClinical and Experimental Dermatology|December 2, 2021
Isotretinoin prescribing and monitoring practices among Australian dermatologists measured against current guidelines, and identification of practice uncertaintiesNicholas Manuelpillai, Emma VeyseyClinical and Experimental Dermatology|December 4, 2021
Eczematous drug eruption in patients with psoriasis under anti-interleukin-17A: does interleukin-22 play a key role?Matteo Megna, Giuseppina Caiazzo, Melania Parisi, et al.Clinical and Experimental Dermatology|November 26, 2021
Otological complications in inversa type recessive dystrophic epidermolysis bullosaS J Robertson, C Prodinger, L Liu, et al.Clinical and Experimental Dermatology|November 26, 2021
Frontal fibrosing alopecia: survey of severity assessment methods in routine clinical practice and validation of the International Frontal Fibrosing Alopecia Cooperative Group measurement guidanceD M Cummins, C Marshall, L Asfour, et al.Clinical and Experimental Dermatology|November 21, 2018
Arsenic enhances cell death and DNA damage induced by ultraviolet B exposure in mouse epidermal cells through the production of reactive oxygen speciesY Yin, F Meng, C Sui, et al.Clinical and Experimental Dermatology|February 16, 2019
A 14-year review of a UK teledermatology service: experience of over 40 000 teleconsultationsS H Mehrtens, L Shall, S M HalpernClinical and Experimental Dermatology|April 1, 2019
Family recurrence risk of alopecia areata in the Faroe IslandsE W Jacobsen, O B Pedersen, G Andorsdóttir, et al.Clinical and Experimental Dermatology|August 17, 2019
Efficacy and safety of HAT1 compared with calcipotriol in the treatment of patients with mild to moderate chronic plaque psoriasis: results from an open-label randomized comparative pilot clinical studyP Alex, S Williams, L Sutton, et al.Clinical and Experimental Dermatology|August 17, 2019
Downregulation of kynureninase restrains cutaneous squamous cell carcinoma proliferation and represses the PI3K/AKT pathwayC Ci, C Wu, D Lyu, et al.Pageof 549